Peer-reviewedLicence not statedHeart (British Cardiac Society)
Post Heart Transplantation Immunosuppression and Rejection: What the General Cardiologist Needs to Know
- 1Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA
Related
- Phenotyping Antibody-mediated Rejection Without Detectable Donor-specific Antibodies 8 d After Heart Transplantation: A Case Study
- Association Between Cardiologist Ambulatory Workload and Evidence‐Based Therapy for Heart Failure
- The Tell-Tale Heart ― Persistent Immune Activation in Histologically Rejection-Free Heart Transplant Recipients ―
- A Transfusion-transmitted Chronic Hepatitis E Virus Infection after Allogeneic Bone Marrow Transplantation with Viral Clearance Following Immunosuppression Tapering
- Late-onset Acute Cellular Rejection after Lung Transplantation Triggered by a Fluctuation in the Tacrolimus Trough Level Which Was Successfully Treated with Steroid Pulse Therapy
BibTeX
@article{jain2026post,
title = {{Post Heart Transplantation Immunosuppression and Rejection: What the General Cardiologist Needs to Know}},
author = {Rashmi Jain and Michelle M. Kittleson},
journal = {Heart (British Cardiac Society)},
year = {2026},
month = sep,
doi = {10.1136/heartjnl-2026-328009},
url = {https://doi.org/10.1136/heartjnl-2026-328009},
}
RIS
TY - JOUR
TI - Post Heart Transplantation Immunosuppression and Rejection: What the General Cardiologist Needs to Know
AU - Rashmi Jain
AU - Michelle M. Kittleson
PY - 2026
DA - 2026/09/21
JO - Heart (British Cardiac Society)
DO - 10.1136/heartjnl-2026-328009
UR - https://doi.org/10.1136/heartjnl-2026-328009
SN - 1355-6037
SN - 1468-201X
ER -